CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Entrectinib

恩曲替尼 杂质对照品Entrectinib Impurities

34 个杂质条目34 impurity entries

本页汇总 恩曲替尼 的 34 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Entrectinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 恩曲替尼(Entrectinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsLC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib
    Journal of pharmaceutical and biomedical analysis · 2025 · Meertens M et al.  ·  PMID 40743983  ·  DOI
  2. 分析方法Analytical MethodsQuantification and pharmacokinetic study of entrectinib in rat plasma using ultra-performance liquid chromatography tandem mass spectrometry
    Biomedical chromatography : BMC · 2019 · Wang Q et al.  ·  PMID 30549079  ·  DOI

恩曲替尼 —— 原料药与杂质对照品Entrectinib — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Entrectinib structure
原料药 APIAPI
恩曲替尼Entrectinib
Entrectinib
CAS No.1108743-60-7
Chemical FormulaC31H34F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 1 structure
1
恩曲替尼杂质1Entrectinib Impurity 1
Entrectinib Impurity 1
CAS No.1108743-80-1
Chemical FormulaC30H33F2N6O2+
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 2 structure
2
恩曲替尼杂质2Entrectinib Impurity 2
Entrectinib Impurity 2
CAS No.1108745-38-5
Chemical FormulaC33H33F5N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 3 structure
3
恩曲替尼杂质3Entrectinib Impurity 3
Entrectinib Impurity 3
CAS No.1108745-30-7
Chemical FormulaC14H11F2N3
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 4 structure
4
恩曲替尼杂质4Entrectinib Impurity 4
Entrectinib Impurity 4
CAS No.1034975-61-5
Chemical FormulaC19H24F3N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 5 structure
5
恩曲替尼杂质5Entrectinib Impurity 5
Entrectinib Impurity 5
CAS No.1108744-37-1
Chemical FormulaC34H38F2N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 6 structure
6
恩曲替尼杂质6Entrectinib Impurity 6
Entrectinib Impurity 6
CAS No.1889329-44-5
Chemical FormulaC17H24ClN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 7 structure
7
恩曲替尼杂质7Entrectinib Impurity 7
Entrectinib Impurity 7
CAS No.1034976-52-7
Chemical FormulaC19H23ClF3N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 8 structure
8
恩曲替尼杂质8Entrectinib Impurity 8
Entrectinib Impurity 8
CAS No.2664105-09-1
Chemical FormulaC25H30ClN3O4
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 9 structure
9
恩曲替尼杂质9Entrectinib Impurity 9
Entrectinib Impurity 9
CAS No.1034975-53-5
Chemical FormulaC23H32F3N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 10 structure
10
恩曲替尼杂质10Entrectinib Impurity 10
Entrectinib Impurity 10
CAS No.1108747-15-4
Chemical FormulaC32H36F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 11 structure
11
恩曲替尼杂质11Entrectinib Impurity 11
Entrectinib Impurity 11
CAS No.1108743-67-4
Chemical FormulaC32H36F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 12 structure
12
恩曲替尼杂质12Entrectinib Impurity 12
Entrectinib Impurity 12
CAS No.1108743-58-3
Chemical FormulaC31H34F2N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 13 structure
13
恩曲替尼杂质13Entrectinib Impurity 13
Entrectinib Impurity 13
CAS No.2716237-53-3
Chemical FormulaC32H36F2N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 14 structure
14
恩曲替尼杂质14Entrectinib Impurity 14
Entrectinib Impurity 14
CAS No.2247907-12-4
Chemical FormulaC31H34F2N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 15 structure
15
恩曲替尼杂质15Entrectinib Impurity 15
Entrectinib Impurity 15
CAS No.1950688-23-9
Chemical FormulaC31H33BrF2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 16 structure
16
恩曲替尼杂质16Entrectinib Impurity 16
Entrectinib Impurity 16
CAS No.1108744-93-9
Chemical FormulaC33H38F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 17 structure
17
恩曲替尼杂质17Entrectinib Impurity 17
Entrectinib Impurity 17
CAS No.1108743-98-1
Chemical FormulaC32H36F2N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 18 structure
18
恩曲替尼杂质18Entrectinib Impurity 18
Entrectinib Impurity 18
CAS No.2216758-87-9
Chemical FormulaC33H39F2N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 19 structure
19
恩曲替尼杂质19Entrectinib Impurity 19
Entrectinib Impurity 19
CAS No.2698399-35-6
Chemical FormulaC32H35ClF2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 20 structure
20
恩曲替尼杂质20Entrectinib Impurity 20
Entrectinib Impurity 20
CAS No.2698398-22-8
Chemical FormulaC33H37F2N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 21 structure
21
恩曲替尼杂质21Entrectinib Impurity 21
Entrectinib Impurity 21
CAS No.2716237-63-5
Chemical FormulaC32H35F3N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 22 structure
22
恩曲替尼杂质22Entrectinib Impurity 22
Entrectinib Impurity 22
CAS No.2698398-44-4
Chemical FormulaC34H39F2N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 23 structure
23
恩曲替尼杂质23Entrectinib Impurity 23
Entrectinib Impurity 23
CAS No.2412055-66-2
Chemical FormulaC32H34F2N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 24 structure
24
恩曲替尼杂质24Entrectinib Impurity 24
Entrectinib Impurity 24
CAS No.1108743-87-8
Chemical FormulaC31H34F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 25 structure
25
恩曲替尼杂质25Entrectinib Impurity 25
Entrectinib Impurity 25
CAS No.1108747-16-5
Chemical FormulaC32H36F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 26 structure
26
恩曲替尼杂质26Entrectinib Impurity 26
Entrectinib Impurity 26
CAS No.2716237-54-4
Chemical FormulaC29H30F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 27 structure
27
恩曲替尼杂质27Entrectinib Impurity 27
Entrectinib Impurity 27
CAS No.2716237-71-5
Chemical FormulaC32H36F2N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 28 structure
28
恩曲替尼杂质28Entrectinib Impurity 28
Entrectinib Impurity 28
CAS No.1108743-88-9
Chemical FormulaC32H37FN6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 29 structure
29
恩曲替尼杂质29Entrectinib Impurity 29
Entrectinib Impurity 29
CAS No.1889328-83-9
Chemical FormulaC31H35FN6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 30 structure
30
恩曲替尼杂质30Entrectinib Impurity 30
Entrectinib Impurity 30
CAS No.1108743-89-0
Chemical FormulaC31H35FN6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 31 structure
31
恩曲替尼杂质31Entrectinib Impurity 31
Entrectinib Impurity 31
CAS No.2716237-94-2
Chemical FormulaC32H36F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 32 structure
32
恩曲替尼杂质32Entrectinib Impurity 32
Entrectinib Impurity 32
CAS No.2716237-93-1
Chemical FormulaC32H35F3N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 33 structure
33
恩曲替尼杂质33Entrectinib Impurity 33
Entrectinib Impurity 33
CAS No.2716237-95-3
Chemical FormulaC33H37F3N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Entrectinib Impurity 37 structure
37
恩曲替尼杂质37Entrectinib Impurity 37
Entrectinib Impurity 37
CAS No.1108745-33-0
Chemical FormulaC14H12FN3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

恩曲替尼 —— 研究文献与合成路线Entrectinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 恩曲替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Entrectinib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MS
    Attwa MW, Darwish HW, Alhazmi HA, et al. · Clinica chimica acta; international journal of clinical chemistry · 2018 · 被引 25cited 25
  2. Stress degradation study on entrectinib and characterization of its degradation products using HRMS and NMR
    Dhiman V, Singh S, Balhara A, et al. · Journal of pharmaceutical and biomedical analysis · 2022 · 被引 14cited 14

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

恩曲替尼 杂质谱研究要点Entrectinib — impurity profiling notes

下面这些是拿到 恩曲替尼 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Entrectinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances